Found: 96
Select item for more details and to access through your institution.
Tetrabenazine.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.
- Published in:
- Movement Disorders Clinical Practice, 2019, v. 6, n. 7, p. 541, doi. 10.1002/mdc3.12808
- By:
- Publication type:
- Article
Repairing the genomic defect in muscular dystrophy.
- Published in:
- Clinical Genetics, 2000, v. 58, n. 4, p. 265, doi. 10.1034/j.1399-0004.2000.580403.1.x
- By:
- Publication type:
- Article
Shedding new light on the pathogenesis of familial Alzheimer disease.
- Published in:
- Clinical Genetics, 2000, v. 58, n. 4, p. 266, doi. 10.1034/j.1399-0004.2000.580403.2.x
- By:
- Publication type:
- Article
Microbubbles used to ‘pop’ new gene into the heart.
- Published in:
- Clinical Genetics, 2000, v. 58, n. 4, p. 269, doi. 10.1034/j.1399-0004.2000.580403.3.x
- By:
- Publication type:
- Article
HotSpots.
- Published in:
- Clinical Genetics, 1999, v. 55, n. 4, p. 226, doi. 10.1034/j.1399-0004.1999.550402.x
- By:
- Publication type:
- Article
Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling.
- Published in:
- Frontiers in Human Neuroscience, 2015, v. 9, p. 1, doi. 10.3389/fnhum.2015.00634
- By:
- Publication type:
- Article
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 11, p. 4532, doi. 10.1093/brain/awad275
- By:
- Publication type:
- Article
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington's disease mouse model.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 6, p. 2298, doi. 10.1093/brain/awac458
- By:
- Publication type:
- Article
Testing a longitudinal compensation model in premanifest Huntington's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Operationalizing compensation over time in neurodegenerative disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Antisense oligonucleotides targeting miR‐29b binding site increase translation of progranulin protein: potential therapeutic strategy for progranulin‐deficient frontotemporal dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.067828
- By:
- Publication type:
- Article
Visuospatial Processing Deficits Linked to Posterior Brain Regions in Premanifest and Early Stage Huntington's Disease.
- Published in:
- Journal of the International Neuropsychological Society, 2016, v. 22, n. 6, p. 595, doi. 10.1017/S1355617716000321
- By:
- Publication type:
- Article
Natural biological variation of white matter microstructure is accentuated in Huntington's disease.
- Published in:
- Human Brain Mapping, 2018, v. 39, n. 9, p. 3516, doi. 10.1002/hbm.24191
- By:
- Publication type:
- Article
Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease.
- Published in:
- Human Brain Mapping, 2017, v. 38, n. 6, p. 2819, doi. 10.1002/hbm.23527
- By:
- Publication type:
- Article
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
- Published in:
- Human Brain Mapping, 2016, v. 37, n. 12, p. 4615, doi. 10.1002/hbm.23332
- By:
- Publication type:
- Article
Large-Scale Brain Network Abnormalities in Huntington's Disease Revealed by Structural Covariance.
- Published in:
- Human Brain Mapping, 2016, v. 37, n. 1, p. 67, doi. 10.1002/hbm.23014
- By:
- Publication type:
- Article
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
- Published in:
- Human Brain Mapping, 2013, v. 34, n. 3, p. 519, doi. 10.1002/hbm.21449
- By:
- Publication type:
- Article
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 2, p. 189, doi. 10.1016/j.jalz.2012.03.003
- By:
- Publication type:
- Article
Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. 2, p. 176, doi. 10.1016/j.jalz.2012.03.002
- By:
- Publication type:
- Article
Progranulin deficiency leads to altered microglial function and neuroinflammation
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Generation and characterization of a mouse model of progranulin deficiency
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P3-377: A novel pathogenic pathway of immune activation detectable before cinical onset in Huntington's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
- Published in:
- Nature Genetics, 2003, v. 35, n. 1, p. 76, doi. 10.1038/ng1219
- By:
- Publication type:
- Article
Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
- Published in:
- Brain & Behavior, 2023, v. 13, n. 4, p. 1, doi. 10.1002/brb3.2940
- By:
- Publication type:
- Article
Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice.
- Published in:
- Translational Neurodegeneration, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40035-024-00443-8
- By:
- Publication type:
- Article
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.595679
- By:
- Publication type:
- Article
Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion disease.
- Published in:
- BMC Neurology, 2006, v. 6, p. 32, doi. 10.1186/1471-2377-6-32
- By:
- Publication type:
- Article
Longitudinal Structural MRI in Neurologically Healthy Adults.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.
- Published in:
- CNS Drugs, 2022, v. 36, n. 11, p. 1207, doi. 10.1007/s40263-022-00956-8
- By:
- Publication type:
- Article
The Clinical and Genetic Features of Huntington Disease.
- Published in:
- Journal of Geriatric Psychiatry & Neurology, 2010, v. 23, n. 4, p. 243, doi. 10.1177/0891988710383573
- By:
- Publication type:
- Article
Clinical utility gene card for: Huntington's disease.
- Published in:
- European Journal of Human Genetics, 2014, v. 22, n. 5, p. 1, doi. 10.1038/ejhg.2013.206
- By:
- Publication type:
- Article
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 8, p. 2414, doi. 10.1523/JNEUROSCI.5687-08.2009
- By:
- Publication type:
- Article
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease.
- Published in:
- Journal of Neuroscience, 2009, v. 29, n. 7, p. 2193, doi. 10.1523/JNEUROSCI.5473-08.2009
- By:
- Publication type:
- Article
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease.
- Published in:
- Journal of Neuroscience, 2008, p. 2414, doi. 10.1523/JNEUROSCI.5687-08.2009
- By:
- Publication type:
- Article
Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease.
- Published in:
- Journal of Neuroscience, 2005, v. 25, n. 16, p. 4169, doi. 10.1523/JNEUROSCI.0590-05.2005
- By:
- Publication type:
- Article
Huntingtin inhibits caspase-3 activation.
- Published in:
- EMBO Journal, 2006, v. 25, n. 24, p. 5896, doi. 10.1038/sj.emboj.7601445
- By:
- Publication type:
- Article
Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
- Published in:
- BMC Neuroscience, 2006, v. 7, p. 80, doi. 10.1186/1471-2202-7-80
- By:
- Publication type:
- Article
Satellog: A database for the identification and prioritization of satellite repeats in disease association studies.
- Published in:
- BMC Bioinformatics, 2005, v. 6, p. 145, doi. 10.1186/1471-2105-6-145
- By:
- Publication type:
- Article
Development of an α-synuclein knockdown peptide and evaluation of its efficacy in Parkinson's disease models.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01746-6
- By:
- Publication type:
- Article
Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 6, p. 764, doi. 10.1001/jamaneurol.2020.0299
- By:
- Publication type:
- Article
Association of CAG Repeats With Long-term Progression in Huntington Disease.
- Published in:
- JAMA Neurology, 2019, v. 76, n. 11, p. 1375, doi. 10.1001/jamaneurol.2019.2368
- By:
- Publication type:
- Article
Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.
- Published in:
- JAMA Neurology, 2017, v. 74, n. 11, p. 1352, doi. 10.1001/jamaneurol.2017.2107
- By:
- Publication type:
- Article
Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.
- Published in:
- Nature Cell Biology, 2002, v. 4, n. 2, p. 95, doi. 10.1038/ncb735
- By:
- Publication type:
- Article
Medication Use in Early-HD Participants in TrackHD: an Investigation of its Effects on Clinical Performance.
- Published in:
- PLoS Currents, 2016, p. 280, doi. 10.1371/currents.hd.8060298fac1801b01ccea6acc00f97cb
- By:
- Publication type:
- Article
Untargeted metabolomics and infrared ion spectroscopy identify biomarkers for pyridoxine-dependent epilepsy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 1979, doi. 10.1172/JCI80743
- By:
- Publication type:
- Article
White matter predicts functional connectivity in premanifest Huntington's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 2, p. 106, doi. 10.1002/acn3.384
- By:
- Publication type:
- Article
Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model.
- Published in:
- Nature Communications, 2013, v. 4, n. 12, p. 2906, doi. 10.1038/ncomms3906
- By:
- Publication type:
- Article
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
- Published in:
- Journal of Neurochemistry, 2016, v. 139, n. 1, p. 22, doi. 10.1111/jnc.13719
- By:
- Publication type:
- Article